⌘K

Home/Filings/4/0001437749-23-005531

4//SEC Filing

Guse Kyle 4

Accession 0001437749-23-005531

CIK 0001488039other

View on SEC.gov Company Profile

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 4:10 PM ET

Size

5.0 KB

Accession

0001437749-23-005531

Insider Transaction Report

Form 4

Period: 2023-03-02

ATOSSA THERAPEUTICS, INC.ATOS

CFO & General Counsel

Transactions

Award
Stock Option (right to buy)
2023-03-02+557,900→ 557,900 total
Exercise: $0.72Exp: 2033-03-02→ Common Stock (557,900 underlying)

Footnotes (1)

[F1]The option will vest and become exercisable on a quarterly basis over 24 months from the grant-date.

Documents

1 file

4
rdgdoc.xmlPrimary
FORM 4

Issuer

ATOSSA THERAPEUTICS, INC.

CIK 0001488039

Entity typeother

Related Parties

1

filerCIK 0001566618

Filing Metadata

Form type: 4
Filed: Mar 5, 7:00 PM ET
Accepted: Mar 6, 4:10 PM ET
Size: 5.0 KB

View on SEC.gov